Fig. 3From: Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatmentKaplan–Meier estimates for Progression-free survival by post-NACT CTM group (log-rank test of equality, P < 0.001). The numbers below the graph indicate the number of subjects at each follow-upBack to article page